Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms

Published:2015-07-20 Issue:9 Volume:7 Page:1211-1228
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Nyström Alexander¹,Thriene Kerstin¹²³,Mittapalli Venugopal¹,Kern Johannes S¹,Kiritsi Dimitra¹,Dengjel Jörn¹²³⁴,Bruckner‐Tuderman Leena¹³

Affiliation:

1. Department of Dermatology Medical Center ‐ University of Freiburg Freiburg Germany

2. ZBSA Center for Biological Systems Analysis Freiburg Germany

3. FRIAS Freiburg Institute for Advanced Studies Freiburg Germany

4. BIOSS Centre for Biological Signalling Studies University of Freiburg Freiburg Germany

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201505061

Reference63 articles.

1. Targeting the TGFβ signalling pathway in disease

2. Dystrophic Epidermolysis Bullosa: Pathogenesis and Clinical Features

3. Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy

4. Type VII Collagen: The Anchoring Fibril Protein at Fault in Dystrophic Epidermolysis Bullosa

5. Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond the Surface: A Narrative Review Examining the Systemic Impacts of Recessive Dystrophic Epidermolysis Bullosa;Journal of Investigative Dermatology;2024-09

2. Skin matrix meets immunomatrix—Implications for genetic and acquired diseases;JEADV Clinical Practice;2024-08-21

3. Stopping a runaway train: targeting fibrosis in recessive dystrophic epidermolysis bullosa;British Journal of Dermatology;2024-07-19

4. Accelerated Aging and Microsatellite Instability in Recessive Dystrophic Epidermolysis Bullosa–Associated Cutaneous Squamous Cell Carcinoma;Journal of Investigative Dermatology;2024-07

5. Gamma-Secretase Inhibitors Downregulate the Profibrotic NOTCH Signaling Pathway in Recessive Dystrophic Epidermolysis Bullosa;Journal of Investigative Dermatology;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3